| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.400 | None | 1.000 | 22 | 0 | 1993 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
disease | 0.400 | None | 1.000 | 19 | 0 | 2008 | 2018 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.400 | None | 0.933 | 15 | 0 | 2002 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 1994 | 2020 | ||||||||
|
H3.3 histone A | 0.559 | 0.692 | 0.12 |
|
disease | 0.400 | None | 1.000 | 14 | 3 | 2012 | 2020 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
disease | 0.400 | None | 1.000 | 13 | 0 | 1999 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.380 | None | 0.556 | 9 | 2 | 2000 | 2019 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2006 | 2019 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2003 | 2018 | ||||||||
|
polo like kinase 1 | 0.467 | 0.808 | 0.98 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 2002 | 2019 | ||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 1996 | 2020 | ||||||||
|
stathmin 1 | 0.458 | 0.885 | 7.5E-02 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2007 | 2020 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 1993 | 2018 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2005 | 2020 | ||||||||
|
Kruppel like factor 6 | 0.501 | 0.846 | 0.98 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2000 | 2019 | ||||||||
|
protection of telomeres 1 | 0.560 | 0.731 | 0.85 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2015 | 2020 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 1994 | 2019 | ||||||||
|
midkine | 0.494 | 0.808 | 0.23 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2004 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
chloride voltage-gated channel 3 | 0.621 | 0.615 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2003 | 2018 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2001 | 2017 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1999 | 2009 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2008 | 2019 |